News
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
In the market’s rapid rise, the portfolio lagged the Russell 2000® Growth Index in Q2. However, the portfolio remains ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback